Delivery Order SPE2DB22D2206-SPE2DB25FHW30
- Not listed
- The Defense Logistics Agency awarded a $2,069.16 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of AMLOD-VALSA-HCTZ 5-160-25 MG in 30-count packaging. The contract, which is non-set-aside and competitively awarded on a firm fixed price basis, is scheduled for completion by August 5, 2025, with performance to occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $2,250.91 on October 27, 2025, for the supply of AMLOD-VALSA-HCTZ 5-160-25 mg pharmaceutical product in a 30-count package. The order, which is not set aside for any particular business category, represents a firm fixed-price delivery order with an ultimate completion date of October 28, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical products under contract number 4569986643, with an award date of November 12, 2025, and a ceiling value of $3,987.86. The specific delivery consists of AMLOD-VALSA-HCTZ 5-160-12.5 mg tablets (30-count supply), a combination antihypertensive medication used to treat high blood pressure. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies under contract 4569914827, valued at $1,024.14 with a firm fixed price structure. The specific delivery involves AMLOD-VALSA-HCTZ 5-160-25 MG 30S, a combination antihypertensive medication, with an ultimate completion date of November 5, 2025. This non-set-aside, competitively awarded delivery order will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,401.50 to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically AMLOD-VALSA-HCTZ 10-320-25 MG in a 30-count supply. This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no...
- This is a $3,745.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order was placed against the company's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is for AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a...
- This delivery order, awarded June 3, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, represents a firm fixed-price pharmaceutical supply contract valued at $2,975.18. The order calls for delivery of AMLOD-VALSA-HCTZ 10-320-25 MG in a 30-tablet supply to the vendor's location in Conshohocken, Pennsylvania, with completion scheduled for June 4, 2025. The contract was awarded without set-aside designation through competitive procurement, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $13,904.53 to AmerisourceBergen Drug Corp for the pharmaceutical product AMLOD-VALSA-HCTZ 10-320-25 MG 30S, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The product is a combination antihypertensive medication containing amlodipine, valsartan,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,846.73, is for the delivery of AMLOD-VALSA-HCTZ 10-160-12.5MG 30S pharmaceutical products. The contract is a firm fixed-price, delivery order contract with a period of performance through December 2024. Amerisourcebergen Drug Corp is the prime contractor, and the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The order is for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S medication, with a potential value of $1,160.35 and a completion date of February 27, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHW30Delivery Order
This delivery order, awarded to AmerisourceBergen Drug Corp on July 14, 2025, provides for the supply of AMLOD-VALSA-HCTZ 5-160-12.5 mg pharmaceutical products in a 30-count package, with a ceiling value of $2,196.72 and an ultimate completion date of July 15, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded through the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of federal contract awards with the DLA, delivering medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/14/25 |